New study suggests interventions to help patients build muscle before surgery may improve their outcomes.
Low muscle quality and quantity are both predictive of poor outcomes in colon resection surgery, according to a new study published in JAMA Surgery.
Image credit: U.S. Air Force photo by Staff Sgt. Ciara Gosier via af.mil/ Public Domain
Carla Prado, a researcher at the University of Alberta’s Faculty of Agricultural, Life & Environmental Sciences, and her team followed 1,630 patients who received a diagnosis of Stage I to Stage III colon cancer. The researchers examined various outcomes including length of hospital stay, need for readmission and mortality in patients with colon cancer following colon resection surgery.
Carla Prado’s lab created this video explaining need-to-know facts about the impact of nutrition on the human body, and the role it has in preventing and treating low muscle mass. “We’re missing diagnosing people with malnutrition if we’re only looking at people being very thin,” Prado said.
They found that low muscle mass was linked to greater post-operative complications, hospitalization and mortality.
According to the Canadian Cancer Society, in 2020, colorectal cancer is expected to be the second-leading cause of death from cancer in Canadian men and the third-leading cause of death from cancer in women. Surgery is often used to remove cancer, and post-operative complications can affect a patient’s quality of life.
Prado noted that the ability to predict who may suffer poor outcomes after surgery would allow for more personalized treatment and improved patient care.
Patients in the study were assessed using preoperative computerized tomography (CT) scans, a technique that involves taking a series of X-ray images from different angles and using computer technology to create cross-sectional images of the body. Scans are taken during cancer diagnosis, and researchers can also use the images to analyze body composition.
Repurposing CT images of cancer patients for body composition analysis is a technique pioneered by Vickie Baracos, who along with Prado is a member of the Cancer Research Institute of Northern Alberta.
“She established it in cancer, and people from all over the world have been exploring body composition based on this sophisticated analysis,” said Prado.
CT technology is what allows for the added analysis of muscle radiodensity, which is the quality of the muscle itself.
“It’s like you’re looking at a steak and you have fat inside the steak. Our muscles can be like that too, and that’s not good for us—so our study looked at both the mass (the quantity) and also the quality of the muscles, which is the amount of fat infiltration,” said Prado, who holds the Campus Alberta Innovates Chair in Nutrition, Food and Health. She is also director of the Human Nutrition Research Unit at the U of A and has spent much of her career examining the impact of low muscle mass in diseases such as cancer.
Prado said colon cancer patients were of particular interest for a variety of reasons. The CT images obtained span the body to the third lumbar vertebrae, a frame that is ideal for assessing body composition. Many patients with colon cancer also commonly fall into the obese weight range, and studying low muscle mass in patients at higher weights can offer added insight.
According to Prado, the knowledge that low muscle quantity and quality are indicative of poor postoperative outcomes can have a major impact on patient care through targeted patient interventions.
“It is possible to preoperatively improve muscle, and through that intervention, we can better people’s quality of life. So I think exploring ways that we can successfully use this approach is the way of the future,” she said.
The study, “Association of Low Muscle Mass and Low Muscle Radiodensity with Morbidity and Mortality for Colon Cancer Surgery,” was published in JAMA Surgery and received funding through the National Cancer Institute.
Source: University of Alberta